| 英文名称 |
中文名称 |
CAS |
|
Cabazitaxel
|
卡巴他赛 |
183133-96-2 |
|
6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, methanesulfonate, compd. with 1,1′-sulfinylbis[methane] (1:1:)
|
仑伐替尼甲磺酸盐DMSO溶剂化物 |
917572-43-1 |
|
lenvatinib Mesylate
|
甲磺酸仑伐替尼 |
857890-39-2 |
|
Lenvatinib Impurity
|
仑伐替尼杂质N |
2143930-77-0 |
|
Apalutamide
|
阿帕鲁胺 |
956104-40-8 |
|
ABT-199
|
维奈妥拉 |
1257044-40-8 |
|
Rucaparib
|
瑞卡帕布 |
1327258-57-0 |
|
Crisaborole
|
克立硼罗 |
906673-24-3 |
|
Capecitabine
|
卡培他滨 |
154361-50-9 |
|
Oseltamivir phosphate
|
磷酸奥司他韦 |
204255-11-8 |
|
Lapatinib impurity A；2-chloro-4-((6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-yl)amino)phenol
|
拉帕替尼杂质 |
1268997-70-1 |
|
Lapatinib impurity B；N-De[2-(Methylsulfonyl)ethyl] Lapatinib
|
拉帕替尼杂质O |
697299-82-4 |
|
Lapatinib impurity D；N-De[2-(Methylsulfonyl)ethyl] Lapatinib
|
N-(3-氯-4-((2-氟苄氧基)苯基)-6-(5-(((2-(甲磺酰基)乙基)胺)甲基)呋喃-2-基)喹唑啉-4-胺 |
1393112-45-2 |
|
Afatinib impurity;Afatinib Impurity des-EJA
|
(S,E)-N-(4-(3-氯-4-氟苯基胺基)-7-((四氢呋喃-3-基)氧基)-6-喹唑啉)-2-丁烯酰胺 |
2223677-64-1 |
|
Afatinib impurity;Ethyl hydrogen (2-((4-((3-chloro-4-fluorophenyl)amino) -7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate
|
(2-((4-((3-氯-4-氟苯基)氨基)-7-(((S)四氢呋喃-3-基)氧基-6-喹唑啉基)氨基)-2-乙氧基)膦酸单乙酯 |
1680184-59-1 |
|
Lapatinib impurity E；N-(3-chloro-4-((4-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate)
|
拉帕替尼杂质 |
1026818-86-9 |
|
Lapatinib impurity F；Lapatinib IMpurity 8
|
5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-呋喃甲醇 |
320337-48-2 |
|
Lapatinib impurity G；5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde
|
5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉]-2-呋喃甲醛 |
231278-84-5 |
|
Lapatinib impurity I；Lapatinib impurity P
|
拉帕替尼杂质P |
633370-23-7 |
|
Lapatinib impurity J；3-Chloro-4-(3-fluorobenzyloxy)aniline
|
3-氯-4-(3-氟苄氧基)苯胺 |
202197-26-0 |
|
Lapatinib impurity H;Lapatinib Impurity 4
|
N-（3-氯-4-（（3-氟苄基）氧基）苯基）-6-（5-（（5-（4-（（3-氯-4-（（3-氟苄基）氧基）苯基）氨基）喹唑啉-6-基）呋喃-2-基）甲基）（2-（甲磺酰基）乙基）氨基）甲基）呋喃-2-基）喹唑啉-4-胺 |
2172855-57-9 |
|
Roxadustat
|
罗沙司他 |
808118-40-3 |
|
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, hydrochloride, hydrate (1:1:2)
|
尼洛替尼单盐二水 |
923289-71-8 |
|
Abiraterone
|
17-(3-吡啶基)-雄甾-5,16-二烯-3β–醇；阿比特龙杂质B |
154229-19-3 |
|
Abiraterone Impurity
|
17-（3-吡啶基）雄甾-5,16-二烯-3β-（2-四氢吡喃基)-醇；阿比特龙杂质D |
1431753-70-6 |
|
Abiraterone Impurity
|
17-(4-吡啶基)-雄甾-5,16-二烯-3β–乙酸酯；阿比特龙杂质F |
165334-69-0 |
|
4-Dimethylaminopyridine
|
4-二甲氨基吡啶；阿比特龙杂质I |
1122-58-3 |
|
Sorafenib tosylate
|
索拉非尼FORMI |
475207-59-1 |
|
(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
阿比特龙杂质J |
|
|
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
阿比特龙杂质k |
1239-13-6 |
|
Palbociclib impurity C
|
6-乙酰基-8-环己基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮；哌柏西利杂质C |
|
|
4-Amino-3-fluorophenol
|
4-氨基-3氟苯酚；瑞戈非尼杂质A |
399-95-1 |
|
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE
|
4-(4-氨基-3-氟苯氧基)-N-甲基吡啶酰胺；瑞戈非尼杂质B |
757251-39-1 |
|
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide
|
4-[3-氟-4-[[2-(甲基氨基甲酰基)吡啶-4-基]氨基]苯氧基]-N-甲基吡啶酰胺；瑞戈非尼杂质D |
1855006-12-0 |
|
FLUCOFURON
|
1-[4-氯-3-(三氟甲基)苯基]-3-[4-氯-3-(三氟甲基)苯基]脲；瑞戈非尼杂质F |
370-50-3 |
|
Regorafenib Impurity
|
4-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-[4-[3-[4-氯-3-(三氟甲基)苯基]脲基]-3-氟苯氧基]苯氧基]-N-甲基吡啶酰胺；瑞戈非尼杂质I |
2098799-13-2 |
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
|
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸；尼洛替尼杂质A |
641569-94-0 |
|
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-
|
4-甲基-3-((5-氯-4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺；尼洛替尼杂质D |
2469039-94-7 |
|
Olaparib
|
奥拉帕利 |
763113-22-0 |
|
Nintedanib Ethanesulfonate Salt
|
乙磺酸尼达尼布 |
656247-18-6 |
|
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
|
德拉沙星 |
442526-91-2 |
|
Neratinib
|
来那替尼 |
698387-09-6 |
|
Regorafenib
|
瑞戈非尼 |
755037-03-7 |
|
Afatinib diMaleate
|
双马来酸盐阿法替尼 |
850140-73-7 |
|
1-(4-cyano-3-(trifluoroMethyl)phenyl)-3-(3-cyano-4-(trifluoroMethyl)phenyl)thiourea
|
恩扎卢胺杂质；1,3-双-（4-氰基-3-三氟甲基-苯基）-硫脲 |
1415564-70-3 |
|
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine
|
恩扎卢胺杂质P |
1289942-66-0 |
|
relugolix impurity
|
6-(6-氨基苯基）-1-(2,6-二氟苄基)-5-(二甲氨基)甲基-3-(6-甲氧基哒嗪-3-基）噻吩[2,3-d]嘧啶-2,4(1H,3H)-二酮 |
1589503-93-4 |
|
Enzalutamide Impurity 9
|
恩扎卢胺杂质 |
1895865-10-7 |
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
|
瑞博西尼杂质A |
1139453-98-7 |
|
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
尼达尼布杂质B |
2093243-16-2 |
|
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-hydroxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
|
瑞卢戈利杂质 |
1801551-07-4 |
|
BIBF 1202
|
尼达尼布杂质A |
894783-71-2 |
|
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
|
尼达尼布杂质G |
262368-30-9 |
|
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
尼达尼布杂质C |
2097505-01-4 |
|
Oxo Enzalutamide
|
恩扎卢胺杂质 |
1242137-18-3 |
|
Enzalutamide carboxylic acid
|
恩扎卢胺杂质I |
1242137-15-0 |
|
1-Piperazinecarboxylic acid, 4-[6-[[7-cyclopentyl-6-[(diMethylaMino)carbonyl]-7H-pyrrolo[2,3-d]pyriMidin-2-yl]aMino]-3-pyridinyl]-, 1,1-diMethylethyl ester
|
瑞博西尼杂质E |
1374639-78-7 |
|
4-[1-(4-cyano-3-trifluoromethyl-phenylcarbamoyl)-1-methyl-ethylamino]-2-fluoro-N-
|
恩扎卢胺杂质 |
1289942-55-7 |
|
4-Amino-2-(trifluoromethyl)benzonitrile
|
恩扎卢胺杂质；4-氨基-2-三氟甲基-苄腈 |
654-70-6 |
|
N,N''-Bis[3-(trifluoromethyl-4-cyanophenyl]urea
|
恩扎卢胺杂质J |
1895865-11-8 |
|
5'-Deoxy-5-fluorocytidine
|
卡培他滨杂质A |
66335-38-4 |
|
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
|
卡培他滨杂质C |
161599-46-8 |
|
5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine
|
卡培他滨杂质E |
910129-15-6 |
|
Capecitabine-2',3'-cyclic Carbonate
|
卡培他滨杂质F |
921769-65-5 |
|
Doxifluridine
|
卡培他滨杂质B |
3094-09-5 |
|
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine
|
卡培他滨杂质D |
162204-30-0 |
|
Carfilzomib
|
卡非佐米 |
868540-17-4 |
|
Ribociclib
|
瑞博西尼 |
1374639-79-8 |
|
Lapatinib ditosylate
|
二甲苯磺酸拉帕替尼 |
388082-78-8 |
|
Enzalutamide
|
恩扎卢胺 |
1242137-16-1 |
|
Dasatinib
|
达沙替尼 |
302962-49-8 |
|
Afatinib
|
阿法替尼 |
850140-72-6 |
|
Irinotecan hydrochloride trihydrate
|
盐酸伊立替康 |
136572-09-3 |
|
Tedizolid Phosphate
|
磷酸特地唑胺 |
856867-55-5 |
|
Abiraterone acetate
|
醋酸阿比特龙 |
154229-18-2 |
|
Elagolix Sodium
|
依拉格力 |
832720-36-2 |
|
Bortezomib
|
硼替佐米 |
179324-69-7 |
|
Pemetrexed Disodium Heptahydrate
|
培美曲塞七水物 |
357166-29-1 |
|
brivaracetam
|
布瓦西坦 |
357336-20-0 |
|
(S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate
|
(S)-2-(4-(3-氯-4-氟苯基氨基)-7-(四氢呋喃-3-基氧基)喹唑啉-6-基氨基)-2-氧代乙基膦酸二乙酯 |
618061-76-0 |
|
Afatinib impurity;(R,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
|
(R,E)-N-{4-[(3-氯-4-氟苯基)氨基]-7-[(四氢呋喃-3-基)氧基]喹唑啉-6-基}-4-(二甲基氨基)丁-2-烯酰胺 |
945553-91-3 |
|
Afatinib impurity；
|
(E)-N-(4-((3-氯-4-氟苯基)胺)-7-乙氧基喹唑啉-6-基)-4-(二甲氨基)丁-2-烯酰胺 |
2085843-51-0 |
|
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide
|
4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(3-(5-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)苯甲酰胺；尼洛替尼杂质C |
641571-15-5 |
|
NILOTINIB IMPURITY
|
4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-乙基基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺；尼洛替尼杂质F |
2119583-24-1 |
|
5-(piperazin-1-yl)pyridin-2-aMine
|
5-(哌嗪-1-基)吡啶-2-胺;哌柏西利杂质A |
1082876-26-3 |
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-
|
8-环戊基-5-甲基-2-[[(5-哌嗪-1-基吡啶-2-基)]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮；哌柏西利杂质B |
571190-22-2 |
|
Palbociclib impurity D
|
4-[6-[(6-乙酰基-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯 |
1651214-74-2 |
|
Palbociclib impurity E
|
6-溴-8-环戊基-5-甲基-2-[[5-(哌嗪-1-基)吡啶-2-基]氨基]-8H-吡啶并[2,3-D]嘧啶-7-酮 |
851067-56-6 |
|
Palbociclib impurity G
|
8-环戊基-5-甲基-2-（（（5-（哌嗪-1-基）吡啶-2-基）氨基）-6-乙烯基吡啶并[2,3-d]嘧啶-7（8H）-酮 |
2204863-06-7 |
|
4-QuinazolinaMine
|
4-[(3-氯-4-氟苯基)氨基]-6-硝基-7-((S)-四氢呋喃-3-基氧基)-喹唑啉 |
314771-88-5 |
|
3-Amino-4-methylbenzoic acid
|
3-氨基-4-甲基苯甲酸；尼洛替尼杂质H |
2458-12-0 |
|
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
|
3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺；尼洛替尼杂质B |
641571-11-1 |
|
Alectinib hydrochloride
|
阿来替尼 |
1256589-74-8 |
|
relugolix
|
瑞卢戈利 |
737789-87-6 |
|
AKOS BB-3093
|
3-氨基-4-甲基苯甲酸乙酯；尼洛替尼杂质G |
41191-92-8 |
|
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine
|
N4-(3-氯-4-氟苯基)-7-[[(3S)-四氢-3-呋喃基]氧基]-4,6-喹唑啉二胺 |
314771-76-1 |
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester
|
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸；尼洛替尼杂质E |
917392-54-2 |
